Your browser doesn't support javascript.
loading
Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer Cells.
Yang, Chunsong; Wierbilowicz, Krzysztof; Dworak, Natalia M; Bae, Song Yi; Tengse, Sachi B; Abianeh, Nicki; Drake, Justin M; Abbas, Tarek; Ratan, Aakrosh; Wotton, David; Paschal, Bryce M.
Afiliação
  • Yang C; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Wierbilowicz K; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Dworak NM; Center for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Bae SY; Advanced Microscopy Facility, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Tengse SB; Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota.
  • Abianeh N; Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota.
  • Drake JM; Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Abbas T; Department of Pharmacology and Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
  • Ratan A; Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Wotton D; Center for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, Virginia.
  • Paschal BM; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia.
Cancer Res Commun ; 3(4): 592-606, 2023 04.
Article em En | MEDLINE | ID: mdl-37077937

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptores Androgênicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptores Androgênicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article